Herbalife Nutrition has been granted a patent for natural drug compositions containing turmeric, boswellia, and ginger for treating inflammatory disorders and melanoma. The method involves administering a composition with specified extracts to treat inflammation in conditions like Type II diabetes, inflammatory bowel disease, and rheumatoid arthritis. GlobalData’s report on Herbalife Nutrition gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights Herbalife Nutrition Ltd - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Herbalife Nutrition, Low glycaemic index foods was a key innovation area identified from patents. Herbalife Nutrition's grant share as of February 2024 was 49%. Grant share is based on the ratio of number of grants to total number of patents.

Natural drug composition for treating inflammation and melanoma

Source: United States Patent and Trademark Office (USPTO). Credit: Herbalife Nutrition Ltd

A recently granted patent (Publication Number: US11890313B2) discloses a method for treating inflammation in humans caused by disorders such as Type II diabetes, inflammatory bowel disease, and rheumatoid arthritis. The method involves identifying individuals with inflammation due to these specific disorders and administering a composition comprising 50% turmeric extract, 30% Boswellia extract, and 20% ginger extract.

Furthermore, the patent specifies additional details such as the standardization of the turmeric extract to about 95% curcuminoids, the boswellia extract to about 30% boswellic acid (including acetyl-11-keto-beta-boswellic acid), and the ginger extract to about 20% gingerols. The composition also includes specific percentages of lecithin and oil for each extract. Additionally, the method allows for encapsulation of the composition within a liposome for targeted delivery. The patent covers the treatment of specific disorders individually, including Type II diabetes, inflammatory bowel disease, and rheumatoid arthritis, showcasing a tailored approach to addressing inflammation in each case.

To know more about GlobalData’s detailed insights on Herbalife Nutrition, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.